|

A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection

RECRUITINGSponsored by Latin American Cooperative Oncology Group
Actively Recruiting
SponsorLatin American Cooperative Oncology Group
Started2023-06-09
Est. completion2025-04-24
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05328765

Summary

Due to the scarcity of data on prognostic and predictive influence on CCA, epidemiological studies evaluating these factors need to be developed in patients with CCA. Therefore, the investigators want to evaluate the profile of patients in the real world and from various parts of the world, describing prognostic factors such as CD4 dosage, time of HIV infection, evaluation of viral load, diagnosis of AIDS, geographic region of diagnosis and treatment, clinical staging, medications concomitant with QRT (risk of drug interactions), comorbidities (possible impact on dose-intensity), use of HAART, time of use of HAART, radiotherapy modality (conventional 3D vs Modulated Beam Intensity \[IMRT\], response to Nigro vs CTII regimens, as well as comparing clinical outcomes with patients without HIV infection.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients 18 years of age or older
* Confirmed histological diagnosis of anal canal squamous cell carcinoma. Basaloid subtype is accepted
* Have underundered serological test for HIV infection
* Any clinical stage

Exclusion Criteria:

* Lack of data on treatments and clinical outcomes

Conditions3

Anal Squamous Cell CarcinomaCancerHIV Infections

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.